<?xml version="1.0" encoding="UTF-8"?>
<svg height="790.82" width="556.2811649337931" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,491.809,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 14 of 27</text>
  <text x="64.333,70.091,73.927,78.729,82.246,85.608,88.97,92.332" y="33.09299999999996" svg_rhmargin="94.487" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:8.62px;font-style:ITALIC;font-weight:normal;">Cancers </text>
  <text x="94.465,98.807,103.149,107.491" y="33.09299999999996" svg_rhmargin="111.8" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:8.62px;font-style:NORMAL;font-weight:bold;">2018</text>
  <text x="111.831,113.969" y="33.09299999999996" svg_rhmargin="116.124" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:8.62px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="116.108,120.45" y="33.09299999999996" svg_rhmargin="124.759" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:8.62px;font-style:ITALIC;font-weight:normal;">10</text>
  <text x="124.791,126.949,129.087,133.537,135.692,517.025,521.365,523.504,528.24,531.091,533.229,537.57,541.91" y="33.09299999999996" svg_rhmargin="544.065" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:8.62px;font-style:NORMAL;font-weight:normal;">, x 5 of 29 </text>
  <text style="fill:#000000;font-family:IKMAII+TimesNewRoman;font-size:9.72px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="66.763" y="526.5450000000001" x=""/>
  <text y="526.5450000000001" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="482.73" x=""/>
  <text x="87.273,92.697,95.935,101.34,107.28,111.062,115.923,118.35300000000001,119.228" y="544.171" svg_rhmargin="124.088" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:9.72px;font-style:NORMAL;font-weight:bold;">Figure 3</text>
  <text x="124.079,126.518,128.948,129.823,135.79,141.456,146.12,148.55,149.425,152.601,157.916,161.764,166.428,170.558,173.736,176.166,177.041,182.891,185.728,191.044,194.222,198.352,200.782,201.591,206.907,210.153,212.583,213.392,221.948,226.614,229.791,234.66,237.905,242.774,248.44,253.309,256.146,261.523,265.653,268.49,272.62,275.05,275.86,280.729,286.113,291.429,297.26,300.438,302.868,303.743,310.612,317.114,323.615,326.054,328.484,329.359" y="544.171" svg_rhmargin="332.596" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.72px;font-style:NORMAL;font-weight:normal;">. The forest plots of meta-analysis about CRR: (</text>
  <text x="332.541" y="544.171" svg_rhmargin="337.401" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:9.72px;font-style:NORMAL;font-weight:bold;">a</text>
  <text x="337.401,340.642,343.072,343.947,349.324,354.639,358.482,363.142,367.267,370.44,372.87,373.744,379.59,382.422,387.733,390.906,393.336,394.211,397.451,402.762,406.606,409.036,409.91,416.806,423.303,429.8,432.23,433.104,437.968,443.629,449.572,452.002,452.877,459.772,463.052,465.482,466.356,469.189,474.85,477.28000000000003,478.155,482.28,487.591,490.423,493.256,499.198,501.628,502.503,507.367,513.028,518.971" y="544.171" svg_rhmargin="521.401" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.72px;font-style:NORMAL;font-weight:normal;">) Forest plot for CRR and CI in solid and </text>
  <text x="87.274,92.94,97.606,106.161,111.021,114.2,119.517,122.355,127.672,133.049,135.9,140.225,142.655,143.336,151.891,156.751,159.589,162.428,167.805,173.472,178.341,184.008,188.333,191.172,195.837,199.968,202.398,203.079,208.93,213.8,216.908,219.759,224.425,230.092,233.27,237.401,239.83100000000002,240.511,245.828,249.075,251.505,252.185,256.851,261.646,265.971,271.638,274.068,274.748,278.879,281.988,287.82,293.783,299.16,301.59000000000003,302.27,307.14,312.807,318.755,321.185,321.866,325.044,330.711,335.377,337.807,338.487,343.804,349.305,353.971,357.82,362.69,365.528,368.366,370.806,373.236,373.916" y="558.168" svg_rhmargin="377.153" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.72px;font-style:NORMAL;font-weight:normal;">hematologic malignancies patients of each study and the overall; (</text>
  <text x="376.995" y="558.168" svg_rhmargin="382.934" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:9.72px;font-style:NORMAL;font-weight:bold;">b</text>
  <text x="382.956,386.194,388.624,389.304,394.709,400.017,403.858,408.458,412.581,415.75,418.18,418.861,424.703,427.533,432.841,436.011,438.44100000000003,439.121,442.359,447.667,451.507,453.937,454.618,461.51,468.004,474.498,476.928,477.608,482.469,488.127,494.067,496.497,497.178,504.07,507.347,509.777,510.457,513.287,518.945" y="558.168" svg_rhmargin="521.375" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.72px;font-style:NORMAL;font-weight:normal;">) Forest plot for CRR and CI in </text>
  <text x="87.274,93.223,96.062,99.31,102.557,107.224,111.074,115.741,121.408,124.588,126.986,132.935,136.183,140.509,145.109,147.949,150.788,153.186,161.741,166.601,169.441,172.28,177.657,183.325,188.195,193.863,198.189,201.029,205.695,209.827,212.289,218.056,222.916,226.096,228.935,233.601,239.269,242.448,246.58,249.043,254.36,257.536,259.998,264.664,269.459,273.786,279.453,281.851,285.983,289.163,294.995,300.958,306.335,308.797,313.668,319.336,325.285,327.747,330.927,336.594,341.195,343.593,348.911,354.413,359.08,362.93,367.8,370.64,373.479,375.877" y="572.294" svg_rhmargin="378.307" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.72px;font-style:NORMAL;font-weight:normal;">different B-cell malignancies patients of each study and the overall. </text>
  <text x="64.333,69.741,72.443,77.851,80.553,83.209,93.422,97.568,101.168,105.969,109.57,117.38,123.393,128.126,131.131,136.538,140.745,143.75,147.956,150.678,155.479,158.485,161.206,168.421,174.434,181.043,188.258,190.915,195.716,198.721,201.443,208.658,216.468,223.682,226.404,233.013,235.735,242.276,247.719,251.926,256.077,260.874,266.277,271.681,274.402,277.403,283.412,286.134,292.738,297.471,301.067,304.068,308.27,314.279,317.875,322.021,324.742,332.548,335.549,339.145,344.548,347.205,355.616,358.617,361.618,364.619,368.821,373.023,377.225,383.234,386.83,389.552,399.76,404.557,407.558,410.559,415.962,421.971,426.703,432.713,437.109,440.11,444.312,448.458" y="599.51" svg_rhmargin="451.163" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.82px;font-style:ITALIC;font-weight:normal;">2.5. Meta-Analysis of CSER of CAR T Therapy in Patients with Different Malignancies </text>
  <text x="87.273,93.903,100.198,105.379,107.452,112.254,118.159,127.711,137.263,143.169,149.464,151.537,156.122,159.268,165.877,171.057,173.13,178.25,181.85,185.451,190.631,195.433,198.865,203.45,205.524,210.325,215.733,222.255,226.84,232.021,238.629,240.703,246.684,252.697,254.771,262.44,270.856,278.082,280.09,286.72,288.794,292.318,298.613,303.794,308.065,313.473,319.973,325.987,328.005,331.156,337.457,342.263,345.374,351.901,358.515,363.701,370.315,372.389,380.063,387.256,392.94,395.648,397.656,406.598,412.301,414.374,419.787,426.088,432.702,434.775,441.411,447.957,453.641,456.348,458.422,464.44,470.273,474.55,478.08,484.099,487.705,491.268,494.443,500.56,505.745,507.819,512.409,515.939,522.467,529.014,532.124,537.308,541.898" y="620.5699999999999" svg_rhmargin="544.603" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">The common side effects caused by CAR T therapy included CRS, NS and TLS. Forty-five studies </text>
  <text x="64.333,67.962,73.34,78.719,84.162,89.54,94.983,97.656,103.035,108.478,113.856,119.235,124.678,127.351,132.794,138.172,143.551,148.994,154.372,157.045,162.424,167.867,170.54,175.918,181.361,184.018,189.396,194.84,200.218,205.596,211.04,213.713,219.156,224.534,227.207,232.585,238.029,240.702,246.08,251.458,256.902,262.28,267.658,271.287,273.993,278.285,281.46,287.745,292.518,295.693,302.186,308.759,311.892,318.174,324.174,326.88,331.172,336.567,342.01,347.454,350.16,354.452,360.866,366.309,369.821,372.996,378.163,384.445,387.957,392.529,395.235,399.527,408.536,413.703,417.962,423.129,425.83500000000004,430.127,435.295,438.428,441.56,447.561,450.736,456.695,459.871,465.054,467.76,471.988,475.616,481.514,485.772,488.478,492.77,496.282,502.564,507.731,510.437,514.73,522.386,528.051,534.647,541.905" y="635.085" svg_rhmargin="544.61" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">[14–17,19–30,32–34,36,37,39–49,51,53,55–65] including 896 patients were eligible for the CSER </text>
  <text x="64.333,69.501,75.599,81.042,84.152,90.661,96.105,99.616,102.749,108.641,114.923,117.321,123.214,126.842,129.175,136.832,145.235,152.493,154.891,161.508,163.906,167.418,173.7,178.867,183.125,188.569,195.047,201.048,203.446,206.621,212.906,215.304,221.792,227.235,230.668,233.843,239.01,245.292,248.804,253.376,255.709,264.718,267.893,271.405,277.687,280.085,284.657,290.549,293.682,296.857,303.453,305.786,311.229,317.45,324.045,326.443,332.725,337.893,347.432,352.875,356.387,362.279,365.454,371.352,377.353,380.485,385.274,387.672,397.211,402.655,405.787,408.962,414.963,421.245,426.688,432.973,437.762,440.937,446.104,450.677,453.366,455.764,461.764,464.939,469.198,473.77,477.281,480.414,486.415,489.104,491.502,495.014,501.296,506.463,508.796,514.688,520.786,525.954,530.212,535.655,538.788,541.921" y="649.665" svg_rhmargin="544.626" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">evaluation of CAR T therapy in patients with solid and hematologic malignancies. Firstly, the overall </text>
  <text x="64.333,69.526,74.123,77.62,80.795,90.323,95.766,99.263,104.383,106.91,112.827,116.391,118.918,126.564,133.822,139.461,141.988,146.2,151.643,155.141,160.324,162.786,168.206,174.512,181.133,183.595,188.973,194.417,203.515,206.042,213.689,217.254,219.78,223.393,227.676,233.593,243.055,245.582,249.08,255.365,260.557,263.084,266.242,272.549,279.095,282.27,288.361,291.536,298.082,304.562,309.982,313.092,315.619,320.216,323.713,330.247,336.793,339.951,345.143,349.681,352.207,361.241,366.433,370.717,375.836,378.298,383.718,389.137,398.146,400.673,404.236,409.615,415.034,424.133,426.66,434.306,437.936,440.593,443.055,448.474,453.852,459.231,464.65,470.07,479.079,482.691,485.347,487.874,496.908,500.066,503.499,509.784,512.31,517.689,520.216,526.522,529.633,535.658,541.878" y="664.245" svg_rhmargin="544.583" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">estimate of CRS rate and 95% CI from the individual studies were 57% (95% CI: 46–66%), with a high </text>
  <text x="64.333,70.624,75.8,79.32,84.496,88.763,94.664,100.673,105.849,112.14,117.316,120.457,123.978,129.987,132.385,135.981" y="678.825" svg_rhmargin="139.628" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">heterogeneity (I</text>
  <text x="139.631" y="676.104" svg_rhmargin="142.871" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:6.48px;font-style:NORMAL;font-weight:normal;">2</text>
  <text y="678.825" svg_rhmargin="178.303" x="145.269,150.647,153.045,158.424,163.867,172.925,175.598" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">= 74%, </text>
  <text x="177.992" y="678.825" svg_rhmargin="183.403" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.82px;font-style:ITALIC;font-weight:normal;">p</text>
  <text y="678.825" svg_rhmargin="544.642" x="185.769,191.194,193.527,198.952,201.608,207.033,212.412,216.029,218.362,221.98,228.011,231.121,237.146,243.685,247.897,253.094,255.428,260.852,266.231,269.848,272.568,274.966,281.614,287.926,293.046,297.322,302.52,306.138,312.06,316.272,321.392,324.113,326.511,335.551,340.748,343.146,349.626,354.183,359.358,365.962,368.36,371.879,378.168,383.343,385.676,389.942,395.344,401.634,408.237,414.137,423.684,427.279,432.454,436.049,439.644,444.819,449.551,453.07,455.468,465.015,470.915,477.518,482.693,485.833,488.232,491.751,497.651,500.049,504.845,510.247,513.387,518.184,524.7,527.841,533.243,536.762,541.937" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">&lt; 0.01) (Figure 4a). Therefore, we used the random-effect model to calculate </text>
  <text x="64.333,67.835,74.107,79.265,88.794,91.474,94.18,94.779,101.386,107.659,112.816,115.522,116.121,123.703,130.961,136.616,139.322,139.921,144.17,149.613,153.115,158.272,160.97799999999998,161.577,170.576,175.961,180.524,183.23,183.829,188.391,191.566,197.557,203.829,206.952,210.581,213.756,218.488,223.931,230.216,233.718,236.893,242.884,245.58999999999997,246.189,252.461,255.636,261.627,267.899,273.057,277.305,280.011,280.61,284.239,290.137,294.385,297.091,297.743,304.221,309.665,313.167,316.29,321.448,327.72,331.222,335.784,338.49,339.09,348.09,351.266,354.768,361.04,363.74600000000004,364.346,370.618,375.776,385.305,390.75,394.251,400.134,403.31,409.209,415.2,418.376,423.155,425.861,426.461,435.99,441.375,444.551,447.727,453.753,460.025,465.469,471.742,476.521,479.697,484.881,489.444,492.685,496.262,501.707,507.092,516.156,518.835,521.541,522.141,527.526,532.911,541.975" y="693.405" svg_rhmargin="544.68" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">them. The CRS rate was significantly higher for patients with hematologic malignancies (67%, 95% </text>
  <text x="64.333,71.98,75.609,78.324,81.03,82.666,88.087,93.465,98.843,104.264,109.684,118.693,122.307,125.013,126.583,131.398,137.316,146.844,153.323,158.743,163.027,168.221,174.842,177.548,179.184,182.682,188.579,191.285,192.856,199.335,204.778,208.276,211.451,216.644,222.952,226.449,231.052,233.75799999999998,235.393,244.428,247.587,251.085,257.305,260.011,261.647,266.245,272.163,275.322,278.432,285.054,287.76,289.395,298.923,304.301,307.46,310.57,316.597,322.817,328.237,334.545,339.36,342.519,347.638,352.241,354.947,356.582,360.146,365.524,370.945,380.045,382.76,385.466,387.036,392.457,397.878,406.977,409.683,411.319,418.966,422.595,425.252,427.958,429.593,434.972,440.35,445.793,451.172,456.615,465.715,469.278,471.993,474.699,476.335,482.026,487.219,492.034,497.952,504.173,510.783,513.894,519.918,522.633,525.339,526.975,530.472,536.757,541.951" y="707.985" svg_rhmargin="544.656" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">CI: 57–76%) compared to patients with solid malignancies (35%, 95% CI: 20–55%). Secondly, the </text>
  <text x="64.333,70.252,76.343,81.536,85.821,91.241,94.351,97.51,100.21600000000001,101.01,106.203,110.801,114.299,117.474,126.936,132.379,135.877,141.061,143.767,144.56,153.563,159.254,161.95999999999998,162.754,166.965,172.409,175.906,181.09,183.796,184.589,189.968,196.253,202.875,205.581,206.374,211.795,217.215,226.315,229.021,229.815,237.461,241.091,243.797,244.591,248.154,252.366,258.284,267.812,270.51800000000003,271.311,274.809,281.094,286.287,288.993,289.787,292.946,299.254,305.876,309.034,315.126,318.236,324.858,331.393,336.771,339.946,342.65200000000004,343.446,348.044,351.542,358.077,364.624,367.783,372.976,377.574,380.28000000000003,381.009,390.044,395.237,399.521,404.715,407.421,408.214,413.635,422.735,425.44100000000003,426.235,429.798,435.176,440.555,449.629,452.33500000000004,453.128,460.775,464.404,467.12,469.826,470.619,476.04,481.418,486.839,492.217,501.317,504.88,507.596,510.302,511.095,520.13,523.289,526.786,533.072,535.778,536.571" y="722.565" svg_rhmargin="541.982" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">overall estimate NS rate and 95% CI from the individual studies were 8% (95% CI: 5–13%), with a</text>
  <text y="722.565" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.82px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="544.614" x=""/>
  <text x="64.333,70.629,73.776,79.791,86.087,88.793,90.817,97.113,102.294,105.82,111.001,115.274,121.107,127.121,132.303,138.599,143.78,146.927,150.453,156.467,159.173,161.132,164.734" y="737.08" svg_rhmargin="168.381" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">high heterogeneity (I</text>
  <text x="168.337" y="734.359" svg_rhmargin="171.577" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:6.48px;font-style:NORMAL;font-weight:normal;">2</text>
  <text svg_rhmargin="211.716" y="737.08" x="176.308,181.697,184.403,186.427,191.816,197.259,206.328,209.011,211.71699999999998" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">= 53%, </text>
  <text x="213.697" y="737.08" svg_rhmargin="219.108" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.82px;font-style:ITALIC;font-weight:normal;">p</text>
  <text y="737.08" svg_rhmargin="544.631" x="223.806,229.211,231.917,233.876,239.282,241.982,247.387,252.792,256.391,259.09700000000004,261.121,264.719,270.678,273.822,279.833,286.353,290.623,295.801,298.507,300.466,305.871,311.85,315.448,318.148,320.85400000000004,322.878,329.507,335.799,342.319,346.902,349.602,352.308,354.333,357.855,364.148,369.326,372.03200000000004,374.056,378.268,383.646,389.939,396.545,402.449,411.999,415.597,420.775,424.373,427.971,433.149,437.949,441.471,444.177,446.136,455.687,461.59,468.196,473.374,476.518,479.224,481.248,490.191,495.634,500.217,502.923,504.883,511.403,515.986,521.164,527.77,530.476,532.5,536.023,541.926" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">&lt; 0.01) (Figure 4b). Thus, the random-effect model was used to </text>
  <text x="64.333,69.147,74.566,77.724,82.456,88.99,92.1,97.52,101.017,106.209,108.915,112.495,115.992,122.277,127.397,136.924,139.638,142.344,145.924,152.566,158.873,163.991,166.697,170.277,174.56,179.752,184.29,190.77,193.927,197.425,200.131,203.71,208.523,214.441,220.747,224.311,227.469,231.752,241.316,246.508,253.054,255.76,259.34,262.837,269.122,274.542" y="751.66" svg_rhmargin="278.07" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">calculate them. The result confirmed that</text>
  <text style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.82px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="280.684" y="751.66" x=""/>
  <text x="284.264,287.761,294.029,299.182,301.88800000000003,305.468,314.43,320.081,322.78700000000003,326.366,330.611,336.054,339.551,344.705,347.411,350.99,359.985,365.365,369.923,372.629,376.143,380.701,383.877,387.052,393.076,399.344,402.841,405.96,411.947,414.653,418.232,424.5,427.675,433.661,439.929,445.082,449.327,452.033,455.612,459.24,465.073,469.317,472.023,475.603,482.016,487.46,490.957,494.132,499.285,505.553,508.986,513.588,516.294,519.874,528.868,532.044,535.541,541.809" y="751.66" svg_rhmargin="544.514" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">the NS rate was slightly higher for patients with </text>
  <text x="64.332,70.639,75.831,85.358,90.802,94.299,100.197,103.355,109.272,115.231,118.407,123.22,125.926,126.72,136.247,141.69,144.8,147.975,154.001,160.221,165.641,171.948,176.761,179.919,185.037,189.575,192.28099999999998,193.138,196.702,202.145,211.244,213.901,216.607,217.464,222.843,228.286,237.295,240.00099999999998,240.858,248.505,252.135,254.791,257.497,258.355,263.733,269.111,274.531,279.95,288.959,292.572,295.278,296.135,300.949,306.866,316.328,322.807,328.227,332.474,337.637,344.228,346.934,347.792,351.299,357.187,359.89300000000003,360.751,367.234,372.677,376.185,379.313,384.476,390.754,394.261,398.829,401.535,402.392,411.397,414.572,418.079,424.357,427.06300000000005,427.857,432.425,438.313,441.441,444.57,451.161,453.867,454.725,464.259,469.65,472.825,475.935,481.931,488.209,493.652,499.937,504.722,507.85,513.013,517.581,520.287,521.079,524.708,530.151,539.221,541.906" y="766.24" svg_rhmargin="544.611" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">hematologic malignancies (9%, 95% CI: 4–17%) compared to patients with solid malignancies (6%, </text>
  <text x="64.332,69.775,75.219,84.228,86.949,94.607,98.238,100.929,103.585,109.029,114.424,119.82,125.215,134.29,137.919,140.641,143.362,149.959,155.127,159.701,162.835,169.431,174.6,177.29,180.012,185.905,192.188,195.363,201.388,204.109,210.003,216.286,221.454,224.176,230.664,236.108,239.62,242.795,247.964,254.247,257.76,260.481,266.764,272.207,278.804,281.526,288.144,294.741,300.407,303.098,305.819,309.252,315.537,322.047,326.621,329.277,332.452,335.95,338.672,347.682,353.077,357.651,360.372,366.655,372.549,376.061,378.783,383.951,387.126,390.301,396.261,399.436,405.395,408.57,413.689,416.411,420.039,425.937,430.196,432.918,438.314,444.597,450.04,453.215,459.217,463.79,466.924,471.497,474.154,477.329,483.614,486.336,489.848,496.131,499.306,503.844,506.566,511.139,514.651,521.162,527.759" y="780.82" svg_rhmargin="533.776" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;">95% CI: 3–12%). Beside, only one patient had TLS, thus it was not eligible for analysis in this study</text>
  <text x="533.549" y="780.82" svg_rhmargin="536.254" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.82px;font-style:ITALIC;font-weight:normal;">.</text>
  <text y="780.82" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.82px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="538.911" x=""/>
  <rect style="stroke:blue;stroke-width:0.3;" x="126.217" y="48.645" height="477.641" width="353.808" title="14"/>
  <text x="126.217" y="48.645" class="image" id="image.14.1" width="353" height="477">image.14.1.126_480.49_526</text>
  <text svg_rhmargin="133.652" x="97.795,102.78,105.766,110.751,116.23,119.718,124.20100000000001,126.927,131.41,133.652" y="544.476" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Figure 3. </text>
  <text x="137.877,143.483,148.806,153.187,155.912,158.958,163.951,167.399,171.78,175.658,178.64,181.365,186.862,189.523,194.516,197.498,201.37599999999998,204.101,209.095,212.141,214.866,222.941,227.322,230.304,234.877,237.922,242.495,247.818,252.391,255.052,260.137,264.015,266.676,270.554,273.28,277.852,282.91,287.904,293.418,296.40000000000003,299.116,305.6,311.71,317.819,320.106,322.831" y="544.476" svg_rhmargin="325.877" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The forest plots of meta-analysis about CRR: (</text>
  <text x="325.879" y="544.476" svg_rhmargin="330.362" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">a</text>
  <text x="330.362,333.408,336.133,341.218,346.212,349.659,354.04,357.918,360.90000000000003,363.625,369.122,371.783,376.777,379.759,382.483,385.529,390.523,394.136,396.861,403.345,409.454,415.564,418.289,422.862,428.176,433.764,436.489,442.973,446.055,448.781,451.442,456.765,459.491,463.368,468.362,471.023,473.685,479.273,481.998,486.571,491.894" y="544.476" svg_rhmargin="497.482" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot for CRR and CI in solid and</text>
  <text x="97.795,103.118,107.499,115.574,120.147,123.129,128.122,130.784,135.777,140.862,143.524,147.585,150.109,158.184,162.757,165.418,168.08,173.165,178.488,183.061,188.383,192.444,195.106,199.486,203.36399999999998,205.897,211.394,215.967,218.948,221.61,225.981,231.304,234.286,238.164,240.697,245.691,248.737,251.26,255.641,260.214,264.275,269.59799999999996,272.122,275.999,278.981,284.496,290.084,295.169,297.702,302.275,307.598,313.18600000000004,315.71,318.692,324.015,328.39599999999996,330.92,335.913,341.08,345.461,349.074,353.647,356.308,358.97,361.257,363.927" y="557.298" svg_rhmargin="366.973" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">hematologic malignancies patients of each study and the overall; (</text>
  <text x="366.975" y="557.298" svg_rhmargin="372.453" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">b</text>
  <text x="372.453,375.49899999999997,378.023,383.108,388.101,391.558,395.939,399.817,402.79900000000004,405.323,410.819,413.481,418.474,421.456,423.98,427.026,432.019,435.632,438.165,444.649,450.759,456.869,459.392,463.965,469.288,474.87600000000003,477.4,483.885,486.967,489.5,492.161" y="557.298" svg_rhmargin="497.484" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot for CRR and CI in</text>
  <text x="97.795,103.273,105.883,108.707,111.693,115.988,119.368,123.663,128.882,131.805,134.046,139.525,142.51,146.492,150.786,153.396,156.005,158.246,166.164,170.647,173.256,175.865,180.851,186.069,190.552,195.771,199.752,202.361,206.656,210.458,212.699,218.088,222.571,225.494,228.104,232.399,237.617,240.54,244.34199999999998,246.583,251.479,254.465,256.707,261.001,265.485,269.466,274.684,276.926,280.728,283.651,289.057,294.536,299.521,301.763,306.246,311.464,316.942,319.184,322.107,327.326,331.62100000000004,333.862,338.758,343.824,348.119,351.661,356.144,358.753,361.362" y="570.12" svg_rhmargin="363.604" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">different B-cell malignancies patients of each study and the overall.</text>
  <text x="76.535,81.516,84.007,88.988,91.479,94.567,103.972,107.847,111.165,115.588,118.906,126.099,131.638,136.062,138.831,143.812,147.688,150.457,154.333,156.824,161.247,164.01700000000002,166.507,173.152,178.691,184.779,191.424,193.914,198.338,201.108,203.598,210.243,217.436,224.08100000000002,226.572,232.659,235.15,241.237,246.218,250.093,253.969,258.392,263.374,268.35600000000005,270.846,273.615,279.154,281.645,287.732,292.156,295.473,298.243,302.118,307.657,310.975,314.851,317.341,324.534,327.304,330.621,335.603,338.093,345.844,348.614,351.383,354.153,358.028,361.724,365.6,371.139,374.457,376.947,386.352,390.775,393.545,396.315,401.296,406.835,411.258,416.798,420.852,423.622,427.497" y="591.202" svg_rhmargin="431.372" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:9.96px;font-style:italic;font-weight:normal;">2.5. Meta-Analysis of CSER of CAR T Therapy in Patients with Different Malignancies</text>
  <text x="97.795,104.024,109.938,114.806,118.739,123.25,128.799,137.772,146.745,152.293,158.207,162.13,166.438,169.395,175.604,180.472,184.404,189.272,192.473,195.857,200.724,205.236,208.549,212.858,216.78,221.292,226.373,232.5,236.809,241.677,247.886,251.818,257.438,263.08799999999997,267.01,274.215,282.121,288.909,292.842,299.07099999999997,302.993,306.306,312.22,317.088,321.102,326.183,332.29,337.94,341.873,344.83,350.744,355.256,358.213,364.33,370.539,375.407,381.616,385.548,392.753,399.541,404.876,407.417,411.349,419.794,425.12899999999996,429.051,434.132,440.046,446.255,450.188,456.417,462.626,467.961,470.502,474.424,480.074,485.622,489.636,492.949,498.599,501.983,508.131,513.872" y="610.689" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">The common side effects caused by CAR T therapy included CRS, NS and TLS. Forty-ﬁve</text>
  <text x="76.535,80.755,83.999,90.001,96.082,98.978,103.746,107.966,110.444,113.756,118.737,123.718,128.695,133.676,138.657,141.146,146.127,151.108,156.084,161.065,166.047,168.535,173.516,178.498,183.474,188.455,193.437,195.925,200.906,205.888,208.376,213.357,218.339,220.827,225.808,230.789,235.766,240.747,245.728,248.216,253.197,258.179,260.667,265.648,270.63,273.118,278.099,283.081,288.057,293.038,298.02,301.334,303.812,306.709,312.501,316.92,319.816,325.818,331.899,334.795,340.587,346.121,348.589,353.566,358.542,363.51899999999995,365.996,371.978,376.954,380.199,383.095,387.862,393.655,396.899,401.119,403.598,411.898,416.665,420.418,425.185,427.663,432.43,435.327,438.223,443.756,446.653,452.156,455.053,459.82,462.298,465.612,471.047,474.978,477.446,480.691,486.483,491.25,493.729,500.785,506.01,512.091" y="624.198" svg_rhmargin="518.739" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">studies [14–17,19–30,32–34,36,37,39–49,51,53,55–65] including 896 patients were eligible for the CSER</text>
  <text x="76.535,81.288,86.894,91.856,94.743,100.727,105.688,108.923,111.81,117.228,123.003,125.484,130.902,134.206,136.677,143.712,151.432,158.06099999999998,160.541,166.624,169.104,172.339,178.114,182.867,186.787,191.748,197.712,203.22899999999998,205.699,208.587,214.362,216.843,222.806,227.768,231.002,233.89,238.643,244.418,247.653,251.85999999999999,254.331,262.606,265.494,268.729,274.50399999999996,276.984,281.192,286.609,289.497,292.385,298.448,300.928,305.889,311.664,317.727,320.198,325.973,330.726,339.488,344.449,347.684,353.102,355.989,361.407,366.924,369.812,374.218,376.698,385.46,390.421,393.309,396.196,401.713,407.488,412.45,418.225,422.63,425.518,430.271,434.478,436.959,440.045,445.562,448.449,452.369,456.576,459.811,462.699,467.104,469.585,472.066,475.3,481.075,485.828,488.309,493.727,499.333,504.086,508.006,512.967,515.855" y="637.708" svg_rhmargin="518.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">evaluation of CAR T therapy in patients with solid and hematologic malignancies. Firstly, the overall</text>
  <text x="76.535,81.403,85.711,89.024,91.981,100.954,106.035,109.348,114.216,117.487,123.036,126.42,129.692,136.896,143.685,149.02,152.292,156.306,161.386,164.699,169.567,172.839,177.92,183.834,190.043,193.315,198.396,203.477,212.013,215.285,222.49,225.91500000000002,229.186,232.57,236.401,241.95,250.923,254.195,257.507,263.422,268.29,271.561,274.518,280.433,286.641,289.599,295.34,298.297,304.506,310.634,315.714,318.671,321.944,326.252,329.565,335.693,341.902,344.859,349.726,354.035,357.307,365.782,370.649,374.491,379.359,382.63,387.711,392.792,401.328,404.6,407.984,413.065,418.146,426.682,429.954,437.159,440.583,443.124,446.396,451.477,456.558,461.639,466.72,471.801,480.337,483.72,486.261,489.726,498.201,501.158,504.471,510.385,513.657" y="651.217" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">estimate of CRS rate and 95% CI from the individual studies were 57% (95% CI: 46–66%), with a</text>
  <text x="76.535,82.449,85.406,91.056,96.97,99.724,105.639,110.506,113.819,118.686,122.517,128.066,133.716,138.583,144.497,149.365,152.322,155.635,161.285,164.029,167.412" y="664.726" svg_rhmargin="170.837" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">high heterogeneity (I</text>
  <text svg_rhmargin="174.627" x="170.841,174.627" y="664.726" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.57px;font-style:NORMAL;font-weight:normal;">2 </text>
  <text svg_rhmargin="208.025" x="177.875,184.033,186.787,191.868,196.949,205.485,208.026" y="664.726" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">= 74%, </text>
  <text svg_rhmargin="215.915" x="210.834,215.915" y="664.726" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:9.96px;font-style:italic;font-weight:normal;">p </text>
  <text x="218.665,224.82299999999998,227.577,232.658,235.198,240.279,245.36,248.744,251.488,254.872,260.522,263.479,269.129,275.256,279.087,283.955,286.709,291.79,296.871,300.255,302.796,306.656,312.886,318.8,323.667,327.509,332.376,335.76,341.308,345.139,350.007,352.548,355.362,363.837,368.705,371.448,377.576,381.885,386.752,392.961,395.715,399.028,404.942,409.81,412.563,416.577,421.658,427.572,433.781,439.33,448.302,451.686,456.544,459.755,463.129,467.996,472.508,475.82099999999997,478.575,487.548,493.096,499.305,504.172,507.129,509.883,513.196" y="664.726" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">&lt; 0.01) (Figure 4a). Therefore, we used the random-effect model to</text>
  <text x="76.535,81.047,86.128,89.085,93.597,99.724,102.681,107.762,111.075,115.943,118.9,122.213,128.127,132.994,141.967,144.508,149.009,155.239,161.153,166.021,168.988,176.192,182.98,188.315,191.272,195.286,200.367,203.68,208.548,211.505,219.98,225.061,229.37,232.337,236.645,239.602,245.252,251.166,254.124,260.271,264.783,269.864,275.778,279.091,282.048,287.698,290.655,296.57,299.527,305.177,311.091,315.958,319.97200000000004,322.94,326.323,331.872,335.886,338.843,344.95,350.031,353.344,356.301,361.168,367.083,370.395,374.704,377.661,386.136,389.093,392.406,398.32,401.287,407.202,412.069,421.042,426.123,429.436,434.984,437.941,443.49,449.14,452.097,456.609,459.566,468.539,473.619,476.577,479.534,485.184,491.098,496.179,502.093,506.605,509.562,514.429" y="678.236" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">calculate them. The CRS rate was signiﬁcantly higher for patients with hematologic malignancies</text>
  <text x="76.207,79.465,84.356,89.248,97.466,99.91199999999999,102.397,107.288,112.18,120.39800000000001,122.883,129.819,133.116,135.562,138.047,142.939,147.83,152.722,157.614,162.505,170.723,173.98100000000002,176.456,180.8,186.142,194.78,200.66,205.552,209.24,213.926,219.903,222.389,225.578,230.92000000000002,233.405,239.284,244.176,247.365,250.212,254.899,260.592,263.782,267.93,270.415,278.574,281.411,284.601,290.295,292.779,296.927,302.269,305.116,307.963,313.94,316.426,325.064,329.956,332.803,335.65,341.089,346.783,351.675,357.369,361.712,364.559,369.245,373.39300000000003,375.878,379.136,384.028,388.92,397.138,399.584,402.068,406.96,411.852,420.07,422.555,429.491,432.788,435.23400000000004,437.719,442.61,447.502,452.393,457.285,462.177,470.395,473.653,476.09900000000005,479.18,484.316,489.003,493.346,498.688,504.382,510.359,513.206,517.54" y="691.745" svg_rhmargin="519.986" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">(67%, 95% CI: 57–76%) compared to patients with solid malignancies (35%, 95% CI: 20–55%). Secondly,</text>
  <text x="76.535,79.832,85.717,90.56099999999999,93.048,98.569,104.282,109.126,113.12,118.176,121.119,124.062,126.549,131.393,135.68,138.977,141.919,150.848,155.904,159.201,164.045,166.522,174.925,180.234,182.722,186.716,191.772,195.068,199.912,202.4,207.456,213.341,219.519,222.007,227.063,232.119,240.613,243.101,250.27,253.678,256.165,259.533,263.345,268.866,277.79499999999996,280.282,283.579,289.464,294.308,296.785,299.728,305.613,311.792,314.734,320.447,323.39,329.569,335.666,340.722,343.66499999999996,346.152,350.44,353.736,359.834,366.012,368.955,373.799,378.08599999999996,380.574,389.007,393.851,397.663,402.507,404.994,410.05,418.544,421.032,424.399,429.455,434.511,443.005,445.493,452.662,456.07,458.598,461.086,466.142,471.198,476.254,481.31,489.804,493.171,495.699,498.187,506.62,509.563,512.859" y="705.255" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">the overall estimate NS rate and 95% CI from the individual studies were 8% (95% CI: 5–13%), with</text>
  <text x="76.535,81.616,84.766,90.68,93.637,99.287,105.20100000000001,108.362,114.276,119.144,122.456,127.324,131.155,136.703,142.353,147.221,153.135,158.003,160.96,164.272,169.922,173.073,176.457" y="718.764" svg_rhmargin="179.882" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">a high heterogeneity (I</text>
  <text svg_rhmargin="183.669" x="179.883,183.669" y="718.764" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.57px;font-style:NORMAL;font-weight:normal;">2 </text>
  <text svg_rhmargin="217.867" x="187.321,193.47899999999998,196.629,201.71,206.791,215.327,217.868" y="718.764" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">= 53%, </text>
  <text svg_rhmargin="226.27" x="221.189,226.26999999999998" y="718.764" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:9.96px;font-style:italic;font-weight:normal;">p </text>
  <text x="229.424,235.582,238.732,243.813,246.354,251.435,256.516,259.90000000000003,263.06,266.444,272.094,275.051,280.701,286.828,290.659,295.527,298.677,303.758,309.378,312.761,315.302,320.383,326.612,332.526,338.654,342.962,345.503,348.816,352.128,358.043,362.911,366.07,370.084,375.165,381.08,387.288,392.837,401.81,405.194,410.061,413.262,416.646,421.514,426.025,429.33799999999997,432.488,441.461,447.01,453.219,458.086,461.043,464.193,472.668,477.749,482.05800000000005,485.218,491.346,495.654,500.522,506.731,509.881,513.194" y="718.764" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">&lt; 0.01) (Figure 4b). Thus, the random-effect model was used to</text>
 </g>
</svg>
